F. Simonin et al., THE HUMAN DELTA-OPIOID RECEPTOR - GENOMIC ORGANIZATION, CDNA CLONING,FUNCTIONAL EXPRESSION, AND DISTRIBUTION IN HUMAN BRAIN, Molecular pharmacology, 46(6), 1994, pp. 1015-1021
We have used the mouse delta-opioid receptor (mDOR) cDNA to isolate th
e mDOR gene and its human homologue. In both species the coding region
is interrupted by two introns with conserved exon-intron boundaries l
ocated after transmembrane domains 1 and 4. Using the polymerase chain
reaction and primers based on the sequence of the cloned human delta-
opioid receptor (hDOR) gene, we have obtained a full length cDNA encod
ing the hDOR from SH-SY5Y neuroblastoma cells. The cDNA sequence is 10
0% identical to the cloned human genomic sequence and 94% identical to
the mouse sequence at the protein level. When expressed in COS cells,
hDOR displays nanomolar affinities for delta-selective ligands, where
as the affinities far mu- and kappa-selective ligands are in the micro
molar range. The delta agonists [D-Ala(2), D-Leu(5)]enkephalin, cyclic
[D-penicillamine(2),D-penicillamine(5)]enkephalin, and BW373U86 effic
iently decrease forskolin-induced cAMP levels in hDOR-expressing COS c
ells, indicating functional coupling of the receptor. The distribution
of hDOR mRNA in human brain was investigated using delta-selective re
verse transcription-polymerase chain reaction amplification, followed
by Southern hybridization with a delta-specific probe. The transcript
is found in cortical areas, including olfactory bulb, hippocampus, and
amygdala, as well as in basal ganglia and hypothalamus. No expression
is detected in internal globus pallidus, thalamus, any investigated b
rainstem structure, or pituitary gland. Taken together, our results in
dicate similar structural, pharmacological, functional, and anatomical
properties for the hDOR and the mDOR and therefore support the use of
rodent models for the study of these receptors in opioid function.